FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161610573> ?p ?o ?g. }

• W2161610573 endingPage "1796" @default.
• W2161610573 startingPage "1787" @default.
• W2161610573 abstract "Previously, we found that the H1 histamine receptor antagonist diphenhydramine induces apoptosis in human acute T-lymphocytic leukemia cells. Since histamine has been shown to act as a growth factor in malignant melanoma cells, we decided to evaluate the in vitro effect of diphenhydramine and other H1 histamine receptor antagonists, such as terfenadine, astemizol and triprolidine on four malignant human melanoma cell lines. These antagonists were found to induce apoptotic cell death in all four melanoma cell lines. Apoptosis was determined by assessment of phosphatidylserine exposure on the surface of the cells and nuclear fragmentation. Importantly, H1 antagonist treatments did not adversely affect the viability of human melanocytes and murine fibroblasts at the same doses and duration of exposure. Treatment of melanoma cells with terfenadine induced DNA damage and caspases 2, 3, 6, 8 and 9 activation. Furthermore, the general caspase inhibitor (z-VAD-FMK) and a selective inhibitor of caspase-2 (z-VDVAD-FMK) protected melanoma cells from terfenadine-induced apoptosis. In contrast, the caspase-8 inhibitor (z-IETD-FMK) was ineffective. In addition, we found that mitochondria are involved in TEF-induced apoptosis, characterized by the dissipation of the mitochondrial transmembrane potential, the release of cytochrome c into the cytosolic compartment and caspase-9 activation. On the basis of these results we conclude that H1 histamine receptor antagonists induce apoptosis in human melanoma cells but not in normal melanocytes and embryonic murine fibroblasts; this apoptosis appears to be caspase-2-dependent and involves the mitochondrial pathway. The present results may contribute to the elaboration of novel therapeutic strategies for the treatment of malignant human melanoma." @default.
• W2161610573 created "2016-06-24" @default.
• W2161610573 creator A5016837398 @default.
• W2161610573 creator A5019609592 @default.
• W2161610573 creator A5023473981 @default.
• W2161610573 creator A5053072841 @default.
• W2161610573 creator A5060747407 @default.
• W2161610573 creator A5076253398 @default.
• W2161610573 creator A5086182089 @default.
• W2161610573 creator A5087863705 @default.
• W2161610573 creator A5088334820 @default.
• W2161610573 date "2006-04-05" @default.
• W2161610573 modified "2023-10-18" @default.
• W2161610573 title "H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells" @default.
• W2161610573 cites W107180956 @default.
• W2161610573 cites W117176610 @default.
• W2161610573 cites W125106425 @default.
• W2161610573 cites W1481748141 @default.
• W2161610573 cites W1518080160 @default.
• W2161610573 cites W152638509 @default.
• W2161610573 cites W1782490506 @default.
• W2161610573 cites W1877788794 @default.
• W2161610573 cites W1972355061 @default.
• W2161610573 cites W1979995768 @default.
• W2161610573 cites W1980921389 @default.
• W2161610573 cites W1989849807 @default.
• W2161610573 cites W1991164947 @default.
• W2161610573 cites W1991958238 @default.
• W2161610573 cites W1997332730 @default.
• W2161610573 cites W1999057673 @default.
• W2161610573 cites W2002555521 @default.
• W2161610573 cites W2008725666 @default.
• W2161610573 cites W2012025231 @default.
• W2161610573 cites W2022305301 @default.
• W2161610573 cites W2022889216 @default.
• W2161610573 cites W2024105041 @default.
• W2161610573 cites W2024341518 @default.
• W2161610573 cites W2024465086 @default.
• W2161610573 cites W2025713628 @default.
• W2161610573 cites W2028781938 @default.
• W2161610573 cites W2029124386 @default.
• W2161610573 cites W2030892254 @default.
• W2161610573 cites W2031658449 @default.
• W2161610573 cites W2039444414 @default.
• W2161610573 cites W2039779394 @default.
• W2161610573 cites W2042578571 @default.
• W2161610573 cites W2042779695 @default.
• W2161610573 cites W2045885471 @default.
• W2161610573 cites W2046440919 @default.
• W2161610573 cites W2052242113 @default.
• W2161610573 cites W2052305452 @default.
• W2161610573 cites W2052466491 @default.
• W2161610573 cites W2055656744 @default.
• W2161610573 cites W2062774884 @default.
• W2161610573 cites W2063760891 @default.
• W2161610573 cites W2064671816 @default.
• W2161610573 cites W2066429786 @default.
• W2161610573 cites W2079884902 @default.
• W2161610573 cites W2082156580 @default.
• W2161610573 cites W2083846015 @default.
• W2161610573 cites W2087213699 @default.
• W2161610573 cites W2089659926 @default.
• W2161610573 cites W2095291532 @default.
• W2161610573 cites W2113999599 @default.
• W2161610573 cites W2140940780 @default.
• W2161610573 cites W2142387525 @default.
• W2161610573 cites W2149399725 @default.
• W2161610573 cites W2157999078 @default.
• W2161610573 cites W2321484251 @default.
• W2161610573 cites W2598661937 @default.
• W2161610573 doi "https://doi.org/10.1093/carcin/bgl021" @default.
• W2161610573 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16569656" @default.
• W2161610573 hasPublicationYear "2006" @default.
• W2161610573 type Work @default.
• W2161610573 sameAs 2161610573 @default.
• W2161610573 citedByCount "50" @default.
• W2161610573 countsByYear W21616105732012 @default.
• W2161610573 countsByYear W21616105732013 @default.
• W2161610573 countsByYear W21616105732015 @default.
• W2161610573 countsByYear W21616105732016 @default.
• W2161610573 countsByYear W21616105732017 @default.
• W2161610573 countsByYear W21616105732018 @default.
• W2161610573 countsByYear W21616105732019 @default.
• W2161610573 countsByYear W21616105732020 @default.
• W2161610573 countsByYear W21616105732021 @default.
• W2161610573 countsByYear W21616105732022 @default.
• W2161610573 countsByYear W21616105732023 @default.
• W2161610573 crossrefType "journal-article" @default.
• W2161610573 hasAuthorship W2161610573A5016837398 @default.
• W2161610573 hasAuthorship W2161610573A5019609592 @default.
• W2161610573 hasAuthorship W2161610573A5023473981 @default.
• W2161610573 hasAuthorship W2161610573A5053072841 @default.
• W2161610573 hasAuthorship W2161610573A5060747407 @default.
• W2161610573 hasAuthorship W2161610573A5076253398 @default.
• W2161610573 hasAuthorship W2161610573A5086182089 @default.
• W2161610573 hasAuthorship W2161610573A5087863705 @default.
• W2161610573 hasAuthorship W2161610573A5088334820 @default.
• W2161610573 hasConcept C10335311 @default.

• next